Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Oral Care to Prevent Oral Mucositis in Estrogen Receptor Positive Metastatic Breast Cancer Patients Treated With Everolimus: Phase III Randomized Control Trial

NCT02376985 is registered in ClinicalTrials.gov with Comprehensive Support Project for Oncology Research as lead sponsor.

NCT NCT02376985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02376985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Oral Care to Prevent Oral Mucositis in Estrogen Receptor Positive Metastatic Breast Cancer Patients Treated With Everolimus: Phase III Randomized Control Trial
Lead sponsor
Comprehensive Support Project for Oncology Research
Phase
Phase 3
Overall status
Completed
Start date
March 26, 2015
Completion date
October 16, 2018
Enrollment
174 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer